Even with early diagnosis, there appears to be a disproportionate toll from breast cancer in black women.
Non-Hodgkin lymphoma relapse is not a cause for increased anxiety if recurrence is quickly addressed with well tolerated therapy.
Older oncology patients are not receiving optimal care because they are being judged by their chronologic age rather than overall level of fitness.
[Cancer Control] New developments in metastatic castration-resistant prostate cancer (mCRPC) have resulted in several new therapies.
From Oncology Nurse Advisor
Sign Up for Free e-newsletters
Cancer Therapy Advisor Articles
- European Society for Medical Oncology (ESMO) Renal Cell Carcinoma Practice Guidelines
- Current and Emerging Therapies for Bone Metastatic Castration-Resistant Prostate Cancer
- Prognostic Factors for Survival in Ewing's Sarcoma Identified
- Surveillance Until Rituximab Retreatment Does Not Increase Anxiety in Non-Hodgkin Lymphoma
- Black Women Disproportionately Affected by Early-Stage Breast Cancer
- Is Ageism Affecting Patients with Prostate Cancer?
- Radiotherapy in Older Women with Early-Stage Breast Cancer after Conserving Treatment
- Continuation or Reintroduction of Bevacizumab Improves Outcomes in Colorectal Cancer
- Gleason Score 9-10 vs. Gleason 8 Associated with Worse Outcomes
- Elevated C-Reactive Protein Linked with Poor Prognosis in Prostate Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|